Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study
Josefina Cortés-Hernández, Carlos Marras Fernández-Cid, Jose Luis Andreu Sánchez, Jaime Calvo Alén, Angel M. García-Aparicio, Elvira Díez Álvarez, Francisco Javier Hidalgo Bermejo, Carlos Coronell, Alessandra Perna, Josep Ordi Ros
10.1016/j.reuma.2022.08.001